NEW YORK and CAMBRIDGE, Mass., May 3, 2023 – Apertura Gene Therapy, a biotechnology company opening opportunities in genetic medicine for treating debilitating diseases with limited options, today announced that academic collaborator and scientific co-founder, Ben Deverman, PhD, Senior Director of Vector Engineering and Institute Scientist at the Broad Institute of MIT and Harvard, will present at […]

Apertura Gene Therapy announced the appointment of gene therapy executive Joseph La Barge as Chief Executive Officer.

NEW YORK and CAMBRIDGE, Mass., May 4, 2022 – Apertura Gene Therapy, a biotechnology company opening opportunities for treating debilitating diseases with limited options for patients, today announced that its academic collaborators will present findings on the Fit4Function AAV capsid engineering platform and non-human primate proof-of-concept data at the 25th Annual Meeting of the American Society of […]

Founded on platform technologies developed by Broad Institute of MIT and Harvard and Harvard Medical School Investigators